| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
120,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,367,647 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120,920 |
|
|
| Total
Value |
$6,367,647 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -426.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-09-17 |
120,920 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-09-03 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
128,220 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-09-17 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
128,220 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-07-09 |
4 |
AS |
$26.96 |
$42,786 |
D/D |
(1,587) |
155,034 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-06-10 |
4 |
AS |
$21.48 |
$42,952 |
D/D |
(2,000) |
158,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-06-11 |
4 |
OE |
$7.96 |
$43,159 |
D/D |
5,422 |
142,792 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-04-08 |
4 |
AS |
$23.39 |
$46,772 |
D/D |
(2,000) |
162,348 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-05-13 |
4 |
AS |
$24.42 |
$48,840 |
D/D |
(2,000) |
160,348 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2016-12-28 |
4 |
S |
$12.31 |
$53,043 |
D/D |
(4,307) |
1,361 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-01 |
4 |
D |
$19.66 |
$54,399 |
D/D |
(2,767) |
138,982 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-09 |
4 |
OE |
$7.96 |
$55,720 |
D/D |
7,000 |
163,589 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-03 |
4 |
OE |
$7.96 |
$55,720 |
D/D |
7,000 |
174,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-09-09 |
4 |
AS |
$31.43 |
$62,860 |
D/D |
(2,000) |
152,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-08-12 |
4 |
AS |
$32.60 |
$65,200 |
D/D |
(2,000) |
154,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-16 |
4 |
D |
$44.13 |
$66,769 |
D/D |
(1,513) |
150,926 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-05-11 |
4 |
AS |
$39.50 |
$70,587 |
D/D |
(1,787) |
165,396 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2017-11-01 |
4 |
OE |
$11.10 |
$73,993 |
D/D |
6,666 |
52,234 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-10-14 |
4 |
AS |
$37.73 |
$75,452 |
D/D |
(2,000) |
150,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-02-27 |
4 |
D |
$13.94 |
$77,130 |
D/D |
(5,533) |
108,696 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-11-11 |
4 |
AS |
$39.56 |
$79,120 |
D/D |
(2,000) |
148,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-08-10 |
4 |
S |
$31.70 |
$79,250 |
D/D |
(2,500) |
158,164 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-09-14 |
4 |
S |
$34.86 |
$87,150 |
D/D |
(2,500) |
155,664 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-07-13 |
4 |
S |
$35.37 |
$88,425 |
D/D |
(2,500) |
160,664 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-11-09 |
4 |
S |
$35.40 |
$88,500 |
D/D |
(2,500) |
150,664 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-10-12 |
4 |
S |
$35.89 |
$89,725 |
D/D |
(2,500) |
153,164 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-01-04 |
4 |
OE |
$7.96 |
$92,957 |
D/D |
11,678 |
162,651 |
0 |
- |
|
132 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
